A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine
Wei Shi, Xiaomei Yang, Shenxia Xie, Dani Zhong, Xuandong Lin, Ziqiang Ding, Siliang Duan, Fengzhen Mo, Aiqun Liu, Shihua Yin, Xiaobing Jiang, Zhi Ping Xu, Xiaoling Lü
Topics & Concepts
Cancer researchCytotoxic T cellCD8Dendritic cellImmunotherapyTumor microenvironmentT cellMedicineAntigenImmunologyBiologyImmune systemIn vitroTumor cellsBiochemistryCancer Immunotherapy and BiomarkersCAR-T cell therapy researchImmunotherapy and Immune Responses